Delivery Order SPE2DR25D1106-SPE2DR26FJD7C
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,240.22 to AmerisourceBergen Drug Corp for the supply of Valganciclovir 450 mg tablets (60-count units). This firm fixed-price contract, awarded on December 10, 2025, with an ultimate completion date of December 11, 2025, represents a non-set-aside competitive award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Valganciclovir HCl 50 mg/ml in an 88 ml formulation, with a contract ceiling value of $8,470.02 and an ultimate completion date of August 6, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and is being performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order falls under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Valganciclovir 450 mg tablets in quantities of 60 units, with a ceiling value of $12,058.08. This non-set-aside, firm fixed-price delivery order is scheduled for completion by July 21, 2025, with fulfillment performed from AmerisourceBergen's Conshohocken, Pennsylvania location. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $4,120.32 to AmerisourceBergen Drug Corp for the supply of Valganciclovir HCL 50 mg/ml in an 88ml formulation. This is a firm fixed price, non-set-aside delivery order with a completion date of September 11, 2025, issued on September 10, 2025. The pharmaceutical product will be delivered to the contractor's location in Conshohocken, Pennsylvania. This delivery order represents a child contract action under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 12, 2025, for the supply of Valganciclovir HCl 50 mg/ml in an 88 ml formulation, with a ceiling value of $1,115.64 and a firm fixed price structure. The order is scheduled for completion by December 15, 2025, and will be fulfilled at the contractor's Conshohocken, Pennsylvania location. This is a non-set-aside competitive award, issued as a delivery order under an existing contract vehicle,...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Valganciclovir 450 mg tablets in quantities of 60 units. This is a firm fixed price delivery order with a ceiling value of $12,934.69 and an ultimate completion date of September 19, 2025. The contract represents a non-set-aside competitive award, with performance to be fulfilled at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Valganciclovir 450 mg tablets (60-count) under a firm fixed-price contract valued at $1,081.86. This is a non-set-aside competitive award with an ultimate completion date of September 19, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order on September 19, 2025, for the supply of Valganciclovir 450 mg tablets in unit dose packages of 20 tablets. This is a firm fixed-price contract valued at $7,046.46, with an ultimate completion date of September 22, 2025. The contract carries no set-aside designation and represents a competitive award. AmerisourceBergen will perform this delivery from its corporate office location in Conshohocken, Pennsylvania. This...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Valganciclovir 450 mg tablets (60-count units) with a ceiling value of $2,163.72. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by September 26, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the awardee, serving as the prime contractor on...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Valganciclovir 450 mg tablets (60-count units) under a firm fixed price contract valued at $23,621.97, with an ultimate completion date of September 25, 2025. This non-set-aside contract was competitively awarded and will be performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal...
- SPE2DR25D1106Indefinite Delivery Contract
- SPE2DR25D1106-SPE2DR26FJD7CDelivery Order
The Defense Logistics Agency awarded a $4,993.37 delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of Valganciclovir HCL 50 mg/ml in an 88 ml quantity. This is a firm fixed-price delivery order with no set-aside designation, employing competitive procurement procedures. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of December 16, 2025. This award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to military healthcare programs. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive contract portfolio with the Defense Logistics Agency demonstrates its capability to fulfill diverse pharmaceutical requirements, from specialized medications to vaccines and medical supplies across multiple therapeutic domains. Valganciclovir is an antiviral medication commonly used in military and veterans' healthcare settings, and this delivery order represents a routine replenishment transaction within the broader pharmaceutical supply relationship between the agency and this established federal contractor.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.0k | 12/14/25 |